{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:40:33Z","timestamp":1792190433149,"version":"4.4.0"},"reference-count":234,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.clim.2026.110765","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T22:44:50Z","timestamp":1787438690000},"page":"110765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Gasdermin-mediated pyroptosis as a prognostic biomarker and therapeutic target in hepatocellular carcinoma"],"prefix":"10.1016","volume":"288","author":[{"given":"Tareq Nayef","family":"AlRamadneh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inoyatillo","family":"Kholmurodov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naina","family":"Boboyeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malathi","family":"Hanumanthayya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadyh Abdul","family":"Alhady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajashree","family":"Panigrahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navin Kumar","family":"Tailor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2026.110765_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1626311","article-title":"Dual function of Gasdermin E: pyroptosis-mediated pan-cancer suppression versus HCC-specific oncogenic activity","volume":"16","author":"Kahaer","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0010","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-025-02506-4","article-title":"Pyroptosis in cancer therapy: a double-edged sword for immune activation and tumor progression","volume":"24","author":"Alishvandi","year":"2025","journal-title":"Mol. Cancer"},{"issue":"12","key":"10.1016\/j.clim.2026.110765_bb0015","article-title":"Hepatocellular carcinoma: Epidemiology, diagnosis and treatment","volume":"7","author":"Mauro","year":"2025","journal-title":"JHEP Rep."},{"issue":"10504","key":"10.1016\/j.clim.2026.110765_bb0020","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0140-6736(25)01042-6","article-title":"The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment","volume":"406","author":"Chan","year":"2025","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0025","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41419-025-07866-9","article-title":"Is pyroptosis a brake or an accelerator in the fate of the tumor?","volume":"16","author":"Hou","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.clim.2026.110765_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1595539","article-title":"Prognostic model construction and immune microenvironment analysis of pyroptosis-related genes in hepatocellular carcinoma based on single-cell RNA sequencing","volume":"16","author":"Shen","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0035","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1007\/s12672-025-03518-8","article-title":"The role of pyroptosis in ovarian cancer","volume":"16","author":"Zhou","year":"2025","journal-title":"Discov. Oncol."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0040","article-title":"Single cell analysis and bioinformatics reveal pyroptosis mechanisms in hepatocellular carcinoma","volume":"16","author":"Luo","year":"2025","journal-title":"Discov. Oncol."},{"issue":"21","key":"10.1016\/j.clim.2026.110765_bb0045","doi-asserted-by":"crossref","first-page":"24117","DOI":"10.18632\/aging.203669","article-title":"Integrated analysis of expression, prognostic value and immune infiltration of GSDMs in hepatocellular carcinoma","volume":"13","author":"Hu","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.clim.2026.110765_bb0050","article-title":"The conflicting role highlights the complexity of GSDMs in cancer","volume":"16","author":"He","year":"2025","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2026.110765_bb0055","doi-asserted-by":"crossref","first-page":"746","DOI":"10.5009\/gnl240599","article-title":"15-year trends in hepatocellular carcinoma: epidemiology, treatment, and outcomes from a hospital-based registry","volume":"19","author":"Kim","year":"2025","journal-title":"Gut Liver"},{"issue":"6","key":"10.1016\/j.clim.2026.110765_bb0060","first-page":"498","article-title":"Advances in the treatment of hepatocellular carcinoma: An overview of the current and evolving therapeutic landscape for clinicians","volume":"75","author":"Moris","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.clim.2026.110765_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107079","article-title":"New insights into nucleic acid sensor AIM2: the potential benefit in targeted therapy for cancer","volume":"200","author":"Cui","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.clim.2026.110765_bb0070","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41422-025-01107-6","article-title":"Pyroptosis: molecular mechanisms and roles in disease","volume":"35","author":"Broz","year":"2025","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-025-01763-6","article-title":"Inflammasomes and pyroptosis in cancer: mechanisms and therapeutic advances","volume":"18","author":"Seo","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.clim.2026.110765_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/biom15030348","article-title":"Triggering pyroptosis in cancer","volume":"15","author":"Johnson","year":"2025","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s43556-025-00249-8","article-title":"GSDMD-mediated pyroptosis: molecular mechanisms, diseases and therapeutic targets","volume":"6","author":"Li","year":"2025","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.clim.2026.110765_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1624770","article-title":"NLRP3 and beyond: inflammasomes as central cellular hub and emerging therapeutic target in inflammation and disease","volume":"16","author":"Pinz\u00f3n-Fern\u00e1ndez","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2026.110765_bb0095","doi-asserted-by":"crossref","first-page":"8131","DOI":"10.2147\/JIR.S526158","article-title":"PANoptosis: cross-talk among apoptosis, necroptosis, and pyroptosis in neurological disorders","volume":"18","author":"Li","year":"2025","journal-title":"J. Inflamm. Res."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0100","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41420-025-02750-z","article-title":"Mitochondrial orchestration of PANoptosis: mechanisms, disease pathogenesis, and emerging therapeutic frontiers","volume":"11","author":"Zhang","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.clim.2026.110765_bb0105","article-title":"Advances in non-apoptotic regulated cell death: implications for malignant tumor treatment","volume":"15","author":"Zhang","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.clim.2026.110765_bb0110","article-title":"A potential strategy to rebuild the tumor immune microenvironment: PANoptosis","volume":"16","author":"Wu","year":"2025","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.clim.2026.110765_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13071745","article-title":"Therapeutic targeting of apoptosis, autophagic cell death, necroptosis, pyroptosis, and ferroptosis pathways in oral squamous cell carcinoma: molecular mechanisms and potential strategies","volume":"13","author":"Hsu","year":"2025","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.clim.2026.110765_bb0120","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s10495-025-02089-x","article-title":"PANoptosis: a potential target of atherosclerotic cardiovascular disease","volume":"30","author":"Jin","year":"2025","journal-title":"Apoptosis"},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0125","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-025-04339-1","article-title":"Targeting panoptosis: a narrative review of its therapeutic potential in kidney disease","volume":"26","author":"Guo","year":"2025","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.clim.2026.110765_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/medsci13040310","article-title":"Emerging insights into the interplay between PANoptosis and autophagy in immune regulation and immune-mediated inflammatory diseases","volume":"13","author":"Sipos","year":"2025","journal-title":"Med. Sci."},{"key":"10.1016\/j.clim.2026.110765_bb0135","article-title":"PANoptosis in autoimmune diseases interplay between apoptosis, necrosis, and pyroptosis","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2026.110765_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2024.102489","article-title":"Inflammasomes and their role in PANoptosomes","volume":"91","author":"Nadella","year":"2024","journal-title":"Curr. Opin. Immunol."},{"issue":"Pt 3","key":"10.1016\/j.clim.2026.110765_bb0145","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.semcancer.2021.07.017","article-title":"Epigenetics in hepatocellular carcinoma","volume":"86","author":"Nagaraju","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"2","key":"10.1016\/j.clim.2026.110765_bb0150","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2217\/epi.14.80","article-title":"Genetic alterations of DNA methylation machinery in human diseases","volume":"7","author":"Hamidi","year":"2015","journal-title":"Epigenomics"},{"issue":"3","key":"10.1016\/j.clim.2026.110765_bb0155","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1042\/BST20180606","article-title":"TET enzymes, DNA demethylation and pluripotency","volume":"47","author":"Ross","year":"2019","journal-title":"Biochem. Soc. Trans."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0160","doi-asserted-by":"crossref","DOI":"10.1186\/s13048-025-01862-5","article-title":"Gene regulation by non-coding RNAs in infertility: a mechanistic review","volume":"18","author":"Borji","year":"2025","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.clim.2026.110765_bb0165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cbpa.2019.01.024","article-title":"The roles of microRNAs in epigenetic regulation","volume":"51","author":"Yao","year":"2019","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"3","key":"10.1016\/j.clim.2026.110765_bb0170","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/15592294.2016.1273308","article-title":"Mutual regulation of microRNAs and DNA methylation in human cancers","volume":"12","author":"Wang","year":"2017","journal-title":"Epigenetics"},{"issue":"2","key":"10.1016\/j.clim.2026.110765_bb0175","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","article-title":"Gene regulation by long non-coding RNAs and its biological functions","volume":"22","author":"Statello","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.clim.2026.110765_bb0180","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.tcb.2017.05.005","article-title":"Gasdermins: effectors of Pyroptosis","volume":"27","author":"Kovacs","year":"2017","journal-title":"Trends Cell Biol."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0185","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1186\/s12885-024-13276-5","article-title":"Identification of pyroptosis-associated miRNAs in the immunoscape and prognosis of hepatocellular carcinoma","volume":"24","author":"Zheng","year":"2024","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0190","doi-asserted-by":"crossref","first-page":"8886","DOI":"10.1038\/s41598-022-13046-y","article-title":"Identification and validation of a novel pyroptosis-related lncRNAs signature associated with prognosis and immune regulation of hepatocellular carcinoma","volume":"12","author":"Zhang","year":"2022","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.clim.2026.110765_bb0195","doi-asserted-by":"crossref","first-page":"585","DOI":"10.17219\/acem\/190201","article-title":"Identification of a pyroptosis-related long noncoding RNA signature for determining the prognosis and immune status of hepatocellular carcinoma patients","volume":"34","author":"Xu","year":"2025","journal-title":"Adv Clin Exp Med Off organ Wroclaw Med Univ."},{"issue":"4","key":"10.1016\/j.clim.2026.110765_bb0200","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/gutjnl-2024-332281","article-title":"Pharmacological activation of STAT1-GSDME pyroptotic circuitry reinforces epigenetic immunotherapy for hepatocellular carcinoma","volume":"74","author":"Tu","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.clim.2026.110765_bb0205","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2014.09.005","article-title":"Epigenetic therapy as a novel approach in hepatocellular carcinoma","volume":"145","author":"Anestopoulos","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0210","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s10555-025-10251-9","article-title":"Mitochondrial alterations and signatures in hepatocellular carcinoma","volume":"44","author":"Chen","year":"2025","journal-title":"Cancer Metastasis Rev."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0215","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2025.2546680","article-title":"Roles of hypoxia inducible factors in viral infection: are they a potential therapeutic target?","volume":"16","author":"Jia","year":"2025","journal-title":"Virulence"},{"issue":"9","key":"10.1016\/j.clim.2026.110765_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29886","article-title":"Long-term persistence of mitochondrial dysfunctions after viral infections and antiviral therapies: a review of mechanisms involved","volume":"96","author":"Gay","year":"2024","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0225","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s44298-025-00110-3","article-title":"Effects of oxidative stress on viral infections: an overview","volume":"3","author":"Kayesh","year":"2025","journal-title":"NPJ Viruses"},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0230","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41392-025-02253-4","article-title":"Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0235","article-title":"Hypoxic gene expression in chronic hepatitis B virus infected patients is not observed in state-of-the-art in vitro and mouse infection models","volume":"10","author":"Liu","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.clim.2026.110765_bb0240","article-title":"Bridging viral hepatitis and liver cancer: emerging concepts in pathogenesis and therapeutic innovation","volume":"5","author":"Zheng","year":"2025","journal-title":"Clin. Transl. Discov."},{"issue":"6","key":"10.1016\/j.clim.2026.110765_bb0245","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2025.5668","article-title":"Metabolic dysfunction-associated steatotic liver disease: pathogenesis, model and treatment (review)","volume":"56","author":"Ma","year":"2025","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.clim.2026.110765_bb0250","article-title":"Dual role of pyroptosis in liver diseases: mechanisms, implications, and therapeutic perspectives","volume":"13","author":"Yang","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.clim.2026.110765_bb0255","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/stresses4030031","article-title":"Endoplasmic reticulum stress signaling in the regulation of hepatic pathological responses","volume":"4","author":"Baral","year":"2024","journal-title":"Stresses"},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0260","article-title":"Therapeutic approaches for liver fibrosis\/cirrhosis by targeting pyroptosis","volume":"20","author":"Qiao","year":"2025","journal-title":"Open Life Sci."},{"issue":"10","key":"10.1016\/j.clim.2026.110765_bb0265","first-page":"878","article-title":"The role of hepatic SIRT1: from metabolic regulation to immune modulation and multi-target therapeutic strategies","volume":"13","author":"Zhang","year":"2025","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.clim.2026.110765_bb0270","article-title":"The mechanisms of NLRP3 inflammasome\/pyroptosis activation and their role in diabetic retinopathy","volume":"14","author":"Zheng","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2026.110765_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/cells14120930","article-title":"Inflammasomes and signaling pathways: key mechanisms in the pathophysiology of sepsis","volume":"14","author":"Saavedra-Torres","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.clim.2026.110765_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2020.100924","article-title":"An overview of the non-canonical inflammasome","volume":"76","author":"Downs","year":"2020","journal-title":"Mol. Asp. Med."},{"issue":"10","key":"10.1016\/j.clim.2026.110765_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.110698","article-title":"From pores to rupture: structural basis and regulation of lytic cell death by gasdermins and NINJ1","volume":"301","author":"Wang","year":"2025","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.clim.2026.110765_bb0290","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s41417-024-00765-9","article-title":"PANoptosis: bridging apoptosis, pyroptosis, and necroptosis in cancer progression and treatment","volume":"31","author":"Gao","year":"2024","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.clim.2026.110765_bb0295","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1529756","article-title":"Epigenetic regulation of transcription factors involved in NLRP3 inflammasome and NF-kB signaling pathways","volume":"16","author":"Kaszycki","year":"2025","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.clim.2026.110765_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/biom15091339","article-title":"Mitochondrial reactive oxygen species: a unifying mechanism in Long COVID and spike protein-associated injury: a narrative review","volume":"15","author":"Lee","year":"2025","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.clim.2026.110765_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2025.167695","article-title":"Endoplasmic reticulum stress in liver fibrosis: mechanisms and therapeutic potential","volume":"1871","author":"Wang","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0310","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41392-024-01958-2","article-title":"Pyroptosis in health and disease: mechanisms, regulation and clinical perspective","volume":"9","author":"Liu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0315","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-025-02344-4","article-title":"Targeting pyroptosis for cancer immunotherapy: mechanistic insights and clinical perspectives","volume":"24","author":"Huang","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.clim.2026.110765_bb0320","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1384109","article-title":"Multiple functions of HMGB1 in cancer","volume":"14","author":"Lv","year":"2024","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0325","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-025-08371-9","article-title":"Organelles and cancer cell pyroptosis: overview and perspectives","volume":"17","author":"Qiu","year":"2025","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0330","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-025-02741-0","article-title":"From mechanisms to markers: role of pyroptosis in revolutionizing thyroid cancer care","volume":"11","author":"Wang","year":"2025","journal-title":"Cell Death Discov."},{"issue":"20","key":"10.1016\/j.clim.2026.110765_bb0335","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1016\/j.molcel.2025.09.007","article-title":"DAMPs in the immunogenicity of cell death","volume":"85","author":"Chen","year":"2025","journal-title":"Mol. Cell"},{"issue":"8","key":"10.1016\/j.clim.2026.110765_bb0340","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.492","article-title":"Pyroptosis, metabolism, and tumor immune microenvironment","volume":"11","author":"Du","year":"2021","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0345","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1186\/s12964-024-01966-3","article-title":"Biological and pharmacological roles of pyroptosis in pulmonary inflammation and fibrosis: recent advances and future directions","volume":"22","author":"Liu","year":"2024","journal-title":"Cell Commun. Signal"},{"issue":"04","key":"10.1016\/j.clim.2026.110765_bb0350","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1042\/BST20253048","article-title":"Temporal dynamics of angiogenesis: the emerging role of mechanoregulated pathways","volume":"53","author":"Zarin-Bal","year":"2025","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.clim.2026.110765_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218077","article-title":"Regulated cell death in cancer: mechanisms, crosstalk, and opportunities for therapy","volume":"635","author":"Meng","year":"2025","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.clim.2026.110765_bb0360","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/gutjnl-2024-332837","article-title":"Spatial single-cell profiling and neighbourhood analysis reveal the determinants of immune architecture connected to checkpoint inhibitor therapy outcome in hepatocellular carcinoma","volume":"74","author":"Sali\u00e9","year":"2025","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.clim.2026.110765_bb0365","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/s41423-025-01308-4","article-title":"Immune microenvironment in hepatocellular carcinoma: from pathogenesis to immunotherapy","volume":"22","author":"Seyhan","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.clim.2026.110765_bb0370","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1680101","article-title":"Integrative single-cell and spatial transcriptomics analysis reveals FLAD1 as a regulator of the immune microenvironment in hepatocellular carcinoma","volume":"16","author":"Zhu","year":"2025","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2026.110765_bb0375","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1136\/gutjnl-2024-332105","article-title":"Spatial single-cell omics: new insights into liver diseases","volume":"75","author":"Suo","year":"2026","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0380","article-title":"Single cell-spatial transcriptomics and bulk multi-omics analysis of heterogeneity and ecosystems in hepatocellular carcinoma","volume":"8","author":"Ye","year":"2024","journal-title":"npj Precis. Oncol."},{"issue":"8","key":"10.1016\/j.clim.2026.110765_bb0385","article-title":"Spatial immune scoring and prediction of HCC outcomes","volume":"7","author":"Piqu\u00e9-Gili","year":"2025","journal-title":"JHEP Rep."},{"key":"10.1016\/j.clim.2026.110765_bb0390","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1146\/annurev-pathmechdis-111523-023520","article-title":"Roles of cellular neighborhoods in hepatocellular carcinoma pathogenesis","volume":"20","author":"Ma","year":"2025","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"10.1016\/j.clim.2026.110765_bb0395","doi-asserted-by":"crossref","DOI":"10.3390\/livers5040062","article-title":"Integrative analysis of single-cell and spatial transcriptomics reveals intratumor heterogeneity shaping the tumor microenvironment in hepatocellular carcinoma","volume":"5","author":"Liu","year":"2025","journal-title":"Livers"},{"key":"10.1016\/j.clim.2026.110765_bb0400","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1629620","article-title":"Targeting ferroptosis, pyroptosis and necroptosis for cancer immunotherapy in melanoma: mechanistic insights and clinical perspectives","volume":"16","author":"Shan","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0405","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-025-03569-3","article-title":"Cracking the code of cancer immunotherapy resistance: emerging roles of pyroptosis and necroptosis","volume":"44","author":"Lei","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0410","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12943-025-02491-8","article-title":"Therapeutic targeting of cell death-immune crosstalk in cancer to rewire the tumor immune microenvironment","volume":"24","author":"Zhang","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.clim.2026.110765_bb0415","first-page":"559","article-title":"Inducing pyroptosis and reprogramming macrophage via zeolitic imidazolate framework encapsulated-fullerene for two-pronged tumor immunotherapy","volume":"56","author":"Sun","year":"2026","journal-title":"Bioact. Mater."},{"issue":"37","key":"10.1016\/j.clim.2026.110765_bb0420","doi-asserted-by":"crossref","first-page":"11485","DOI":"10.1039\/D5TB01024A","article-title":"Overcoming cancer immunotherapy barriers via nanomaterial-mediated pyroptosis","volume":"13","author":"Xie","year":"2025","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.clim.2026.110765_bb0425","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1701405","article-title":"The \u201cDouble-edged sword\u201d effect of cytokines in cancer: coexisting opportunities and challenges","volume":"16","author":"Yin","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0430","article-title":"Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.clim.2026.110765_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111553","article-title":"Gasdermin D restricts anti-tumor immunity during PD-L1 checkpoint blockade","volume":"41","author":"Jiang","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.clim.2026.110765_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109167","article-title":"Inducing vascular normalization: a promising strategy for immunotherapy","volume":"112","author":"Luo","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.clim.2026.110765_bb0445","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-024-06697-4","article-title":"Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy","volume":"15","author":"Mai","year":"2024","journal-title":"Cell Death Dis."},{"issue":"23","key":"10.1016\/j.clim.2026.110765_bb0450","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.71455","article-title":"Dualistic roles of high mobility group box 1 in Cancer and inflammation","volume":"14","author":"Zeng","year":"2025","journal-title":"Cancer Med."},{"key":"10.1016\/j.clim.2026.110765_bb0455","doi-asserted-by":"crossref","DOI":"10.3390\/cells14100741","article-title":"Tumor-associated macrophages: polarization, immunoregulation, and immunotherapy","volume":"14","author":"Saeed","year":"2025","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0460","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1007\/s12672-025-03905-1","article-title":"Metformin\u2019s multifaceted role in colorectal cancer: mechanisms of action and synergy with standard treatments","volume":"16","author":"Kolour","year":"2025","journal-title":"Discov. Oncol."},{"issue":"4","key":"10.1016\/j.clim.2026.110765_bb0465","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.62347\/QJHB2816","article-title":"Disulfiram potentiates cisplatin-induced apoptosis in small cell lung cancer via the inhibition of cystathionine \u03b2-synthase and H(2)S","volume":"15","author":"Wang","year":"2025","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0470","doi-asserted-by":"crossref","first-page":"6081","DOI":"10.1038\/s41598-025-87537-z","article-title":"Metformin inhibits the growth of SCLC cells by inducing autophagy and apoptosis via the suppression of EGFR and AKT signalling","volume":"15","author":"Xia","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2026.110765_bb0475","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1528230","article-title":"The role of autophagy in cancer: from molecular mechanism to therapeutic window","volume":"16","author":"Jalali","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0480","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s12916-025-04180-1","article-title":"Intraoperatively preventive intraperitoneal perfusion chemotherapy with lobaplatin in colorectal cancer: a prospective, randomised, controlled, multicentre study","volume":"23","author":"Su","year":"2025","journal-title":"BMC Med."},{"issue":"26","key":"10.1016\/j.clim.2026.110765_bb0485","doi-asserted-by":"crossref","first-page":"6040","DOI":"10.3390\/ijms26136040","article-title":"Metformin in colorectal Cancer: epidemiological evidence, predictive biomarkers, and implications for prevention and treatment","volume":"24","author":"Myung","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0490","doi-asserted-by":"crossref","first-page":"14359","DOI":"10.1038\/s41598-023-41490-x","article-title":"Nrf2 inhibition increases sensitivity to chemotherapy of colorectal cancer by promoting ferroptosis and pyroptosis","volume":"13","author":"Huang","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2026.110765_bb0495","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jare.2025.08.057","article-title":"Epigenetic orchestration of cancer-immune dynamics: mechanisms, technologies, and clinical advancements","volume":"83","author":"Lu","year":"2026","journal-title":"J. Adv. Res."},{"issue":"12","key":"10.1016\/j.clim.2026.110765_bb0500","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/s41419-023-06382-y","article-title":"The multifaceted roles of GSDME-mediated pyroptosis in cancer: therapeutic strategies and persisting obstacles","volume":"14","author":"Hu","year":"2023","journal-title":"Cell Death Dis."},{"issue":"17","key":"10.1016\/j.clim.2026.110765_bb0505","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17172938","article-title":"The underlying mechanisms and emerging strategies to overcome resistance in breast cancer","volume":"17","author":"Kannan","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.clim.2026.110765_bb0510","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1576781","article-title":"Advances of HDAC inhibitors in tumor therapy: potential applications through immune modulation","volume":"15","author":"Tian","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.clim.2026.110765_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216413","article-title":"Epigenetic regulation of pyroptosis in cancer: molecular pathogenesis and targeting strategies","volume":"575","author":"Zhang","year":"2023","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.clim.2026.110765_bb0520","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.apsb.2024.11.011","article-title":"Nanomaterials evoke pyroptosis boosting cancer immunotherapy","volume":"15","author":"Li","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.clim.2026.110765_bb0525","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2025.1548588","article-title":"Nanotechnology in cancer treatment: revolutionizing strategies against drug resistance","volume":"13","author":"Sabir","year":"2025","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"6","key":"10.1016\/j.clim.2026.110765_bb0530","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1158\/2326-6066.CIR-24-0834","article-title":"In situ delivery of Gasdermin E mRNA promotes antitumor immunity via creatine-elicited type I interferon signaling in monocytes","volume":"13","author":"Li","year":"2025","journal-title":"Cancer Immunol. Res."},{"issue":"2","key":"10.1016\/j.clim.2026.110765_bb0535","first-page":"270","article-title":"Nanoparticles in cancer therapy: strategies to penetrate and modulate the tumor microenvironment \u2013 a review","volume":"6","author":"Minh Hoang","year":"2025","journal-title":"Smart Mater. Med."},{"issue":"6","key":"10.1016\/j.clim.2026.110765_bb0540","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26062633","article-title":"Functionalized nanomaterials in cancer treatment: a review","volume":"26","author":"Guti\u00e9rrez Coronado","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2026.110765_bb0545","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1618751","article-title":"Viral warfare: unleashing engineered oncolytic viruses to outsmart cancer\u2019s defenses","volume":"16","author":"Omolekan","year":"2025","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2026.110765_bb0550","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000633","article-title":"Cordycepin mediates pyroptosis in HCC through the upregulation of TXNIP and synergizes with anti-PD-L1 immunotherapy","volume":"9","author":"Liang","year":"2025","journal-title":"Hepatol. Commun."},{"issue":"6","key":"10.1016\/j.clim.2026.110765_bb0555","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004763","article-title":"Targeting of GSDMD sensitizes HCC to anti-PD-1 by activating cGAS pathway and downregulating PD-L1 expression","volume":"10","author":"Lv","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"7799","key":"10.1016\/j.clim.2026.110765_bb0560","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41586-020-2071-9","article-title":"Gasdermin E suppresses tumour growth by activating anti-tumour immunity","volume":"579","author":"Zhang","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0565","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.immuni.2017.11.013","article-title":"The pore-forming protein Gasdermin D regulates Interleukin-1 secretion from living macrophages","volume":"48","author":"Evavold","year":"2018","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.clim.2026.110765_bb0570","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006781","article-title":"Pyroptosis activates conventional type I dendritic cells to mediate the priming of highly functional anticancer T cells","volume":"12","author":"Inkol","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"12","key":"10.1016\/j.clim.2026.110765_bb0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166538","article-title":"Vesicular stomatitis virus sensitizes immunologically cold tumors to checkpoint blockade by inducing pyroptosis","volume":"1868","author":"Lin","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.clim.2026.110765_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2026.124210","article-title":"Cabozantinib induces NLRP3-CASP1-GSDMD-dependent pyroptosis in hepatocellular carcinoma","volume":"388","author":"Lin","year":"2026","journal-title":"Life Sci."},{"issue":"7854","key":"10.1016\/j.clim.2026.110765_bb0585","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","article-title":"NASH limits anti-tumour surveillance in immunotherapy-treated HCC","volume":"592","author":"Pfister","year":"2021","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.clim.2026.110765_bb0590","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jhep.2012.03.035","article-title":"Inflammasomes in liver diseases","volume":"57","author":"Szabo","year":"2012","journal-title":"J. Hepatol."},{"issue":"12","key":"10.1016\/j.clim.2026.110765_bb0595","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/s41423-024-01231-0","article-title":"Targeting GSDME-mediated macrophage polarization for enhanced antitumor immunity in hepatocellular carcinoma","volume":"21","author":"Chen","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.clim.2026.110765_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101796","article-title":"GSDME has prognostic and immunotherapeutic significance in residual hepatocellular carcinoma after insufficient radiofrequency ablation","volume":"39","author":"Liang","year":"2024","journal-title":"Transl. Oncol."},{"issue":"11","key":"10.1016\/j.clim.2026.110765_bb0605","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2020.4564","article-title":"Efficacy and safety of nivolumab plus ipilimumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib: the CheckMate 040 randomized clinical trial","volume":"6","author":"Yau","year":"2020","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.clim.2026.110765_bb0610","doi-asserted-by":"crossref","first-page":"8277","DOI":"10.2147\/JIR.S532908","article-title":"NLRP3 inflammasome activation in liver disorders: from molecular pathways to therapeutic strategies","volume":"18","author":"Ma","year":"2025","journal-title":"J. Inflamm. Res."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0615","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00018-025-05744-3","article-title":"Mechanisms of drug induced liver injury","volume":"82","author":"Skat-R\u00f8rdam","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.clim.2026.110765_bb0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2021.100321","article-title":"Drug-induced liver injury: a management position paper from the Latin American Association for Study of the liver","volume":"24","author":"Bessone","year":"2021","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.clim.2026.110765_bb0625","unstructured":"Sivagurunathan N, Calivarathan L. Inflammasome activation as a key driver of acetaminophen-induced hepatotoxicity: mechanisms and emerging therapeutics. Gene Expr. 24(3):235\u201349."},{"key":"10.1016\/j.clim.2026.110765_bb0630","article-title":"Novel integrative models to predict the severity of inflammation and fibrosis in patients with drug-induced liver injury","volume":"12","author":"Zhang","year":"2025","journal-title":"Front. Med."},{"key":"10.1016\/j.clim.2026.110765_bb0635","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1669878","article-title":"Inflammatory markers from routine blood tests predict survival in multiple myeloma: a systematic review and meta-analysis","volume":"16","author":"Luo","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0640","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41392-024-02104-8","article-title":"Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics","volume":"10","author":"Ma","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"12","key":"10.1016\/j.clim.2026.110765_bb0645","article-title":"High systemic inflammation response index and increased cardiovascular risk and mortality in MASLD: a prospective cohort study","volume":"7","author":"Zheng","year":"2025","journal-title":"JHEP Rep."},{"key":"10.1016\/j.clim.2026.110765_bb0650","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1539934","article-title":"Phenylethyl isothiocyanate mitigates drug-induced liver injury in mice by inhibiting hepatocyte pyroptosis through the NLRP3-caspase-1-GSDMD pathway","volume":"16","author":"An","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.clim.2026.110765_bb0655","article-title":"Research and application of medicines for treating liver fibrosis: current status and prospects","volume":"16","author":"Chen","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.clim.2026.110765_bb0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108727","article-title":"Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines","volume":"113","author":"Yang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.clim.2026.110765_bb0665","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1680838","article-title":"Combination of PD-1\/PD-L1 and CTLA-4 inhibitors in the treatment of cancer - a brief update","volume":"16","author":"Park","year":"2025","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.clim.2026.110765_bb0670","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1039\/D5MD00167F","article-title":"NLRP3 inflammasome: structure, mechanism, drug-induced organ toxicity, therapeutic strategies, and future perspectives","volume":"16","author":"Singh","year":"2025","journal-title":"RSC Med. Chem."},{"issue":"null","key":"10.1016\/j.clim.2026.110765_bb0675","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.2147\/JHC.S557035","article-title":"Integrated transcriptomic analysis leveraging single-cell and bulk RNA sequencing data to uncover pyroptosis-related prognostic signatures in HCC","volume":"12","author":"Li","year":"2025","journal-title":"J. Hepatocell. Carcinoma"},{"key":"10.1016\/j.clim.2026.110765_bb0680","article-title":"GSDMD is a novel predictive biomarker for immunotherapy response: in the pan-cancer and single cell landscapes","volume":"16","author":"Huang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2026.110765_bb0685","article-title":"Gasdermin E mediates pyroptosis in the progression of hepatocellular carcinoma: a double-edged sword","volume":"12","author":"Lu","year":"2024","journal-title":"Gastroenterol Rep."},{"key":"10.1016\/j.clim.2026.110765_bb0690","first-page":"11","article-title":"A comprehensive study on the prognostic value of pyroptosis-associated genes in hepatocellular carcinoma","volume":"11","author":"Tian","year":"2025","journal-title":"J. Cancer Metastasis Treat."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0695","doi-asserted-by":"crossref","DOI":"10.21037\/jgo-2024-954","article-title":"Identification of a pyroptosis-related gene prognostic signature in patients with hepatocellular carcinoma","volume":"16","author":"Chen","year":"2025","journal-title":"J. Gastrointest. Oncol."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0700","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-024-02285-9","article-title":"Pir-hsa-216911 inhibit pyroptosis in hepatocellular carcinoma by suppressing TLR4 initiated GSDMD activation","volume":"11","author":"Liao","year":"2025","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0705","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s44355-025-00038-8","article-title":"Decoding the molecular and genomic landscape of hepatocellular carcinoma: biomarker discovery, classification frameworks, and therapeutic targeting","volume":"2","author":"Nevi","year":"2025","journal-title":"NPJ Gut Liver"},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0710","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41698-025-01010-8","article-title":"Consensus artificial intelligence-driven prognostic signature for predicting the prognosis of hepatocellular carcinoma: a multi-center and large-scale study","volume":"9","author":"Wen","year":"2025","journal-title":"npj Precis. Oncol."},{"issue":"6","key":"10.1016\/j.clim.2026.110765_bb0715","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ol.2025.15322","article-title":"Immune checkpoint biology in hepatocellular carcinoma (review)","volume":"30","author":"Hsieh","year":"2025","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.clim.2026.110765_bb0720","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1177\/09287329241296358","article-title":"Predicting prognosis, immune landscape, and drug targets with a novel signature for hepatocellular carcinoma","volume":"33","author":"Qiu","year":"2024","journal-title":"Technol. Health Care"},{"key":"10.1016\/j.clim.2026.110765_bb0725","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.2147\/JHC.S521878","article-title":"Hypoxia- and anoikis-related lncRNA signature defines molecular subtypes and predicts prognosis and immunotherapy response in hepatocellular carcinoma","volume":"12","author":"Lu","year":"2025","journal-title":"J. Hepatocell. Carcinoma"},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0730","doi-asserted-by":"crossref","first-page":"9","DOI":"10.17998\/jlc.2024.12.02","article-title":"Molecular and immune landscape of hepatocellular carcinoma for therapeutic development","volume":"25","author":"Suzuki","year":"2025","journal-title":"J. Liver Cancer"},{"issue":"3","key":"10.1016\/j.clim.2026.110765_bb0735","article-title":"Comprehensive analysis of immune subtype characterization on identification of potential cells and drugs to predict response to immune checkpoint inhibitors for hepatocellular carcinoma","volume":"12","author":"Lai","year":"2025","journal-title":"Genes Dis."},{"key":"10.1016\/j.clim.2026.110765_bb0740","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.clicom.2025.12.002","article-title":"Systems immunology meets clinical translation: multi-omic approaches to predict therapy response in cancer and autoimmune disease","volume":"9","author":"Chandra Sekar","year":"2026","journal-title":"Clin. Immunol. Commun."},{"issue":"6","key":"10.1016\/j.clim.2026.110765_bb0745","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00432-025-06232-8","article-title":"A prognostic PET radiomic model for risk stratification in non-small cell lung cancer: integrating radiogenomics and clinical features to predict survival and uncover tumor biology insights","volume":"151","author":"Taheri","year":"2025","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0750","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-96821-x","article-title":"Interplay between MRI radiomics and immune gene expression signatures in oral squamous cell carcinoma","volume":"15","author":"Corti","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0755","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1038\/s41467-025-58675-9","article-title":"Multimodal fusion of radio-pathology and proteogenomics identify integrated glioma subtypes with prognostic and therapeutic opportunities","volume":"16","author":"Liu","year":"2025","journal-title":"Nat. Commun."},{"issue":"22","key":"10.1016\/j.clim.2026.110765_bb0760","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17223638","article-title":"Integrating multi-omics and medical imaging in artificial intelligence-based cancer research: an umbrella review of fusion strategies and applications","volume":"17","author":"Al Marouf","year":"2025","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0765","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41467-025-55847-5","article-title":"Integration of clinical, pathological, radiological, and transcriptomic data improves prediction for first-line immunotherapy outcome in metastatic non-small cell lung cancer","volume":"16","author":"Captier","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2026.110765_bb0770","doi-asserted-by":"crossref","DOI":"10.1177\/15330338251387928","article-title":"An update of AI and radiomics in precision oncology: insights from liver tumors as case models","volume":"24","author":"Granata","year":"2025","journal-title":"Technol. Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0775","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10238-025-01902-w","article-title":"Beyond single biomarkers: multi-omics strategies to predict immunotherapy outcomes in blood cancers","volume":"25","author":"Pirouzbakht","year":"2025","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.clim.2026.110765_bb0780","article-title":"Applications and advances of multi-omics technologies in gastrointestinal tumors","volume":"12","author":"Liu","year":"2025","journal-title":"Front. Med."},{"issue":"3","key":"10.1016\/j.clim.2026.110765_bb0785","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1012905","article-title":"Anticancer drug response prediction integrating multi-omics pathway-based difference features and multiple deep learning techniques","volume":"21","author":"Wu","year":"2025","journal-title":"PLoS Comput. Biol."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0790","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.intonc.2024.10.003","article-title":"Multi-omics synergy in oncology: unraveling the complex interplay of radiomic, genoproteomic, and pathological data","volume":"1","author":"Luo","year":"2025","journal-title":"Intell. Oncol."},{"issue":"4","key":"10.1016\/j.clim.2026.110765_bb0795","article-title":"Deciphering immune predictors of immunotherapy response: a multiomics approach at the pan-cancer level","volume":"6","author":"Li","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.clim.2026.110765_bb0800","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.748039","article-title":"Identification and validation of Pyroptosis-related gene signature to predict prognosis and reveal immune infiltration in hepatocellular carcinoma","volume":"9","author":"Fu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.clim.2026.110765_bb0805","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1661545","article-title":"Infiltration characteristics and regulatory mechanisms of CD8+ T lymphocytes in solid tumors: spatial distribution, biological functions, and interactions with the immune microenvironment","volume":"16","author":"Ouyang","year":"2025","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.clim.2026.110765_bb0810","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1038\/s41416-024-02849-7","article-title":"Specific features of \u00df-catenin-mutated hepatocellular carcinomas","volume":"131","author":"Dantzer","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.clim.2026.110765_bb0815","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15082338","article-title":"Multi-view radiomics feature fusion reveals distinct immuno-oncological characteristics and clinical prognoses in hepatocellular carcinoma","volume":"15","author":"Gu","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0820","doi-asserted-by":"crossref","DOI":"10.1007\/s10238-025-01965-9","article-title":"AI-driven multi-omics integration in precision oncology: bridging the data deluge to clinical decisions","volume":"26","author":"Hsu","year":"2025","journal-title":"Clin. Exp. Med."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0825","doi-asserted-by":"crossref","DOI":"10.1038\/s41746-025-01471-y","article-title":"Convergence of evolving artificial intelligence and machine learning techniques in precision oncology","volume":"8","author":"Fountzilas","year":"2025","journal-title":"NPJ Digit. Med."},{"key":"10.1016\/j.clim.2026.110765_bb0830","article-title":"ATP6AP1 drives pyroptosis-mediated immune evasion in hepatocellular carcinoma: a machine learning-guided therapeutic target","volume":"16","author":"Tang","year":"2025","journal-title":"Discov. Oncol."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0835","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12672-025-01821-y","article-title":"Convergence of nanotechnology and artificial intelligence in the fight against liver cancer: a comprehensive review","volume":"16","author":"Bhange","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.clim.2026.110765_bb0840","doi-asserted-by":"crossref","DOI":"10.3389\/frai.2025.1624877","article-title":"From data-driven cities to data-driven tumors: dynamic digital twins for adaptive oncology","volume":"8","author":"Karaman","year":"2025","journal-title":"Front. Artif. Intell."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0845","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-025-06371-z","article-title":"From virtual to reality: innovative practices of digital twins in tumor therapy","volume":"23","author":"Shen","year":"2025","journal-title":"J. Transl. Med."},{"issue":"10","key":"10.1016\/j.clim.2026.110765_bb0850","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14103574","article-title":"Exploring the potential of digital twins in Cancer treatment: a narrative review of reviews","volume":"14","author":"Giansanti","year":"2025","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0855","doi-asserted-by":"crossref","DOI":"10.1007\/s13721-026-00757-9","article-title":"Root-cause immunotherapy: AI-guided TCR strategies to eradicate leukemic stem cells in myeloid malignancies","volume":"15","author":"Borji","year":"2026","journal-title":"Netw. Model. Anal. Health Inform. Bioinform."},{"key":"10.1016\/j.clim.2026.110765_bb0860","doi-asserted-by":"crossref","first-page":"41","DOI":"10.21037\/tgh-20-242","article-title":"Artificial intelligence in the detection, characterisation and prediction of hepatocellular carcinoma: a narrative review","volume":"7","author":"Kawka","year":"2022","journal-title":"Transl. Gastroenterol. Hepatol."},{"issue":"10","key":"10.1016\/j.clim.2026.110765_bb0865","doi-asserted-by":"crossref","DOI":"10.3390\/genes13101770","article-title":"Integrative histology-genomic analysis predicts hepatocellular carcinoma prognosis using deep learning","volume":"13","author":"Hou","year":"2022","journal-title":"Genes"},{"issue":"7","key":"10.1016\/j.clim.2026.110765_bb0870","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","article-title":"Comprehensive and integrative genomic characterization of hepatocellular carcinoma","volume":"169","author":"Ally","year":"2017","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.clim.2026.110765_bb0875","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.cell.2019.08.052","article-title":"Integrated Proteogenomic characterization of HBV-related hepatocellular carcinoma","volume":"179","author":"Gao","year":"2019","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.clim.2026.110765_bb0880","doi-asserted-by":"crossref","DOI":"10.31083\/j.fbl2810235","article-title":"The pyroptosis-related signature composed of GSDMC predicts prognosis and contributes to growth and metastasis of hepatocellular carcinoma","volume":"28","author":"Li","year":"2023","journal-title":"Front. Biosci."},{"issue":"4","key":"10.1016\/j.clim.2026.110765_bb0885","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cell.2019.10.003","article-title":"Landscape and dynamics of single immune cells in hepatocellular carcinoma","volume":"179","author":"Zhang","year":"2019","journal-title":"Cell"},{"issue":"7938","key":"10.1016\/j.clim.2026.110765_bb0890","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41586-022-05400-x","article-title":"Liver tumour immune microenvironment subtypes and neutrophil heterogeneity","volume":"612","author":"Xue","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.clim.2026.110765_bb0895","article-title":"The pyroptosis-related long noncoding RNA signature predicts prognosis and indicates immunotherapeutic efficiency in hepatocellular carcinoma","volume":"10","author":"Wang","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"11","key":"10.1016\/j.clim.2026.110765_bb0900","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/kjm2.12901","article-title":"The role of artificial intelligence in the management of liver diseases","volume":"40","author":"Lu","year":"2024","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"4","key":"10.1016\/j.clim.2026.110765_bb0905","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/bib\/bbv108","article-title":"Dimension reduction techniques for the integrative analysis of multi-omics data","volume":"17","author":"Meng","year":"2016","journal-title":"Brief. Bioinform."},{"issue":"10","key":"10.1016\/j.clim.2026.110765_bb0910","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nrg2825","article-title":"Tackling the widespread and critical impact of batch effects in high-throughput data","volume":"11","author":"Leek","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.clim.2026.110765_bb0915","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.clim.2026.110765_bb0920","first-page":"245","article-title":"The application of eXplainable artificial intelligence in studying cognition: a scoping review","volume":"10","author":"Mahmood","year":"2024","journal-title":"Ibrain"},{"issue":"7","key":"10.1016\/j.clim.2026.110765_bb0925","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/s41590-023-01526-w","article-title":"Molecular mechanisms of gasdermin D pore-forming activity","volume":"24","author":"Devant","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2026.110765_bb0930","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-070904","article-title":"Reporting guideline for the early stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI","volume":"377","author":"Vasey","year":"2022","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0935","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41698-025-01042-0","article-title":"Cell graph analysis in hepatocellular carcinoma: predicting local recurrence and identifying spatial relationship biomarkers","volume":"9","author":"Yuan","year":"2025","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.clim.2026.110765_bb0940","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1600129","article-title":"Deep spatial sequencing revealing differential immune responses in human hepatocellular carcinoma","volume":"13","author":"Yu","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"issue":"19","key":"10.1016\/j.clim.2026.110765_bb0945","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17193210","article-title":"Spatial transcriptomics reveals distinct architectures but shared vulnerabilities in primary and metastatic liver tumors","volume":"17","author":"Adapa","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clim.2026.110765_bb0950","series-title":"Graph Neural Networks for Spatial Analysis of Tumor Microenvironments","author":"Badmus","year":"2025"},{"key":"10.1016\/j.clim.2026.110765_bb0955","doi-asserted-by":"crossref","DOI":"10.3389\/fbinf.2025.1669236","article-title":"Spatial heterogeneity reveals an evolutionary signature predicting therapeutic response and clinical outcomes in hepatocellular carcinoma","volume":"5","author":"Luo","year":"2025","journal-title":"Front. Bioinform."},{"issue":"11","key":"10.1016\/j.clim.2026.110765_bb0960","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41419-024-07195-3","article-title":"DKK1+ tumor cells inhibited the infiltration of CCL19+ fibroblasts and plasma cells contributing to worse immunotherapy response in hepatocellular carcinoma","volume":"15","author":"Fan","year":"2024","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.clim.2026.110765_bb0965","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202500770","article-title":"Spatially resolved transcriptomics: revealing tumor microenvironment heterogeneity to advance cancer immunotherapy","volume":"9","author":"Liu","year":"2025","journal-title":"Small Methods"},{"issue":"n\/a","key":"10.1016\/j.clim.2026.110765_bb0970","article-title":"Spatial transcriptomics and snRNA-seq expose CAF niches orchestrating dual stromal-immune barriers in hepatocellular carcinoma","volume":"n\/a","author":"Li","year":"2025","journal-title":"Adv. Sci."},{"issue":"10","key":"10.1016\/j.clim.2026.110765_bb0975","doi-asserted-by":"crossref","DOI":"10.31083\/FBL37633","article-title":"Artificial intelligence in the evolution of interventional therapy for liver cancer: navigating the tumor microenvironment","volume":"30","author":"Xiu","year":"2025","journal-title":"Front. Biosci."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0980","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s12672-025-02421-6","article-title":"Pyroptosis drives tumor progression and immune evasion in hepatocellular carcinoma: a single-cell and spatial transcriptomic study","volume":"16","author":"Tao","year":"2025","journal-title":"Discov. Oncol."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0985","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10565-025-10025-7","article-title":"Lipotoxicity, lipid peroxidation and ferroptosis: a dilemma in cancer therapy","volume":"41","author":"Ma","year":"2025","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.clim.2026.110765_bb0990","article-title":"Pyroptosis in hepatocellular carcinoma: a retrospective analysis","volume":"5","author":"Wang","year":"2025","journal-title":"J. Cancer Ther. Res."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb0995","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41420-024-02116-x","article-title":"Programmed cell death in hepatocellular carcinoma: mechanisms and therapeutic prospects","volume":"10","author":"Wu","year":"2024","journal-title":"Cell Death Discov."},{"issue":"11","key":"10.1016\/j.clim.2026.110765_bb1000","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/s41419-024-07244-x","article-title":"Emerging mechanisms of lipid peroxidation in regulated cell death and its physiological implications","volume":"15","author":"Zheng","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.clim.2026.110765_bb1005","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2025.1578693","article-title":"Copper metabolism in hepatocellular carcinoma: from molecular mechanisms to therapeutic opportunities","volume":"12","author":"Pang","year":"2025","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.clim.2026.110765_bb1010","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16081491","article-title":"Induction of the inflammasome pathway by tyrosine kinase inhibitors provides an actionable therapeutic target for hepatocellular carcinoma","volume":"16","author":"Tutusaus","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.clim.2026.110765_bb1015","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2025.2532217","article-title":"Lenvatinib promotes hepatocellular carcinoma pyroptosis by regulating GSDME palmitoylation","volume":"26","author":"Yuan","year":"2025","journal-title":"Cancer Biol. Ther."},{"issue":"4","key":"10.1016\/j.clim.2026.110765_bb1020","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1007\/s11030-025-11421-1","article-title":"Exploration of the protein and pharmacological landscape of monkeypox virus treatment: from entry point to end point","volume":"30","author":"Aram","year":"2026","journal-title":"Mol. Divers."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb1025","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s12964-025-02416-4","article-title":"Review: progress of the NLRP3 inflammasome in tumours and perspectives for cholangiocarcinoma","volume":"23","author":"Zhuo","year":"2025","journal-title":"Cell Commun. Signal"},{"issue":"6","key":"10.1016\/j.clim.2026.110765_bb1030","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1039\/D2SC05709C","article-title":"AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor","volume":"14","author":"Ren","year":"2023","journal-title":"Chem. Sci."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb1035","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/s41467-024-55259-x","article-title":"Intricacies of human\u2013AI interaction in dynamic decision-making for precision oncology","volume":"16","author":"Niraula","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2026.110765_bb1040","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1630831","article-title":"Mapping artificial intelligence adoption in hepatology practice and research: challenges and opportunities in MENA region","volume":"12","author":"El-Kassas","year":"2025","journal-title":"Front. Med."},{"key":"10.1016\/j.clim.2026.110765_bb1045","article-title":"The application of artificial intelligence-based tools in the management of hepatocellular carcinoma: current status and future perspectives","volume":"11","author":"Celsa","year":"2025","journal-title":"Hepatoma Res."},{"key":"10.1016\/j.clim.2026.110765_bb1050","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.3390\/cancers17213419","article-title":"AI-based cancer models in oncology: from diagnosis to ADC drug prediction","author":"Sobhani","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.clim.2026.110765_bb1055","doi-asserted-by":"crossref","DOI":"10.1038\/s41746-025-01794-w","article-title":"Responsible artificial intelligence governance in oncology","volume":"8","author":"Stetson","year":"2025","journal-title":"NPJ Digit. Med."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb1060","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1007\/s12672-025-03254-z","article-title":"Artificial intelligence-driven pathomics in hepatocellular carcinoma: current developments, challenges and perspectives","volume":"16","author":"Ding","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.clim.2026.110765_bb1065","article-title":"Integrating artificial intelligence in clinical practice, hospital management, and health policy: literature review","volume":"9","author":"Nasef","year":"2025","journal-title":"J. Hosp. Manag. Heal. Policy"},{"issue":"3","key":"10.1016\/j.clim.2026.110765_bb1070","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics15030252","article-title":"Clinical applications of artificial intelligence (AI) in human cancer: is it time to update the diagnostic and predictive models in managing hepatocellular carcinoma (HCC)?","volume":"15","author":"Romeo","year":"2025","journal-title":"Diagnostics"},{"key":"10.1016\/j.clim.2026.110765_bb1075","article-title":"Harnessing multi-omics and artificial intelligence: revolutionizing prognosis and treatment in hepatocellular carcinoma","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.clim.2026.110765_bb1080","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1080\/15376516.2025.2524749","article-title":"Chronological activation of the NLRP3 inflammasome\/pyroptosis pathway in the progression from metabolic dysfunction-associated fatty liver disease to hepatocellular carcinoma","volume":"35","author":"M\u00e1rquez-Quiroga","year":"2025","journal-title":"Toxicol. Mech. Methods"},{"issue":"29","key":"10.1016\/j.clim.2026.110765_bb1085","doi-asserted-by":"crossref","first-page":"13196","DOI":"10.1039\/D5SC01778E","article-title":"Guided multi-objective generative AI to enhance structure-based drug design","volume":"16","author":"Kadan","year":"2025","journal-title":"Chem. Sci."},{"key":"10.1016\/j.clim.2026.110765_bb1090","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70383","article-title":"Artificial intelligence in clinical and translational science: from bench insights to bedside impact","volume":"18","author":"Shahin","year":"2025","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.clim.2026.110765_bb1095","doi-asserted-by":"crossref","DOI":"10.1177\/11795549251384582","article-title":"Navigating cancer complexity: integrative multi-omics methodologies for clinical insights","volume":"19","author":"Catalano","year":"2025","journal-title":"Clin. Med. Insights Oncol."},{"issue":"4","key":"10.1016\/j.clim.2026.110765_bb1100","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s13402-023-00787-9","article-title":"The role of pyroptosis in hepatocellular carcinoma","volume":"46","author":"Zou","year":"2023","journal-title":"Cell. Oncol."},{"issue":"7575","key":"10.1016\/j.clim.2026.110765_bb1105","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"issue":"7661","key":"10.1016\/j.clim.2026.110765_bb1110","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature22393","article-title":"Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin","volume":"547","author":"Wang","year":"2017","journal-title":"Nature"},{"issue":"6494","key":"10.1016\/j.clim.2026.110765_bb1115","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaz7548","article-title":"Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells","volume":"368","author":"Zhou","year":"2020","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.clim.2026.110765_bb1120","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1002\/hep4.2001","article-title":"Spatial transcriptomics identifies enriched gene expression and cell types in human liver fibrosis","volume":"6","author":"Chung","year":"2022","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.clim.2026.110765_bb1125","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41392-019-0062-9","article-title":"Local delivery of arsenic trioxide nanoparticles for hepatocellular carcinoma treatment","volume":"4","author":"Hu","year":"2019","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.clim.2026.110765_bb1130","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1186\/s12951-024-02887-6","article-title":"Co-delivery of polyphyllin II and IR780 PLGA nanoparticles induced pyroptosis combined with photothermal to enhance hepatocellular carcinoma immunotherapy","volume":"22","author":"Huang","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"29","key":"10.1016\/j.clim.2026.110765_bb1135","doi-asserted-by":"crossref","first-page":"25536","DOI":"10.1021\/jacs.5c06039","article-title":"Engineered nano-micro pyroptosis generators: a magnetic-metallo-immunotherapeutic strategy to reinforce transarterial embolization","volume":"147","author":"Wang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.clim.2026.110765_bb1140","article-title":"Pyroptosis in cardiovascular diseases: roles, mechanisms, and clinical implications","volume":"12","author":"Niu","year":"2025","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.clim.2026.110765_bb1145","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1611719","article-title":"Regulation of cancer by inflammasomes: from inflammation to tumorigenesis","volume":"16","author":"Malvankar","year":"2025","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2026.110765_bb1150","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s12276-025-01415-2","article-title":"Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implications","volume":"57","author":"Park","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.clim.2026.110765_bb1155","first-page":"1","article-title":"Optimized therapeutic drug monitoring: the role of machine learning models","author":"Sayadi","year":"2025","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.clim.2026.110765_bb1160","article-title":"Advances in nanoparticles in targeted drug delivery\u2013a review","volume":"19","author":"Islam","year":"2025","journal-title":"Results Surf. Interfaces"},{"issue":"6","key":"10.1016\/j.clim.2026.110765_bb1165","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.annonc.2025.03.005","article-title":"Redefining clinical trial strategic design to support drug approval in medical oncology","volume":"36","author":"Antonarelli","year":"2025","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.clim.2026.110765_bb1170","doi-asserted-by":"crossref","DOI":"10.1016\/j.neucom.2025.131942","article-title":"Ethics of trustworthy AI in healthcare: challenges, principles, and practical pathways","volume":"661","author":"Ahadian","year":"2026","journal-title":"Neurocomputing"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661626001038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661626001038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T18:48:29Z","timestamp":1791744509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661626001038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":234,"alternative-id":["S1521661626001038"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2026.110765","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gasdermin-mediated pyroptosis as a prognostic biomarker and therapeutic target in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2026.110765","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110765"}}